Cabaletta Bio, Inc.
CABA
$3.04
$0.124.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -5.29% | 5.83% | 23.51% | 33.31% | 44.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.64% | 37.64% | 42.72% | 49.69% | 56.58% |
| Operating Income | -33.64% | -37.64% | -42.72% | -49.69% | -56.58% |
| Income Before Tax | -38.39% | -44.87% | -52.19% | -60.35% | -64.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -38.39% | -44.87% | -52.19% | -60.35% | -64.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.39% | -44.87% | -52.19% | -60.35% | -64.91% |
| EBIT | -33.64% | -37.64% | -42.72% | -49.69% | -56.58% |
| EBITDA | -34.32% | -38.21% | -43.15% | -50.11% | -57.14% |
| EPS Basic | 22.84% | 2.53% | -17.76% | -42.44% | -48.12% |
| Normalized Basic EPS | 22.85% | 2.53% | -17.76% | -42.44% | -48.14% |
| EPS Diluted | 22.92% | 2.72% | -17.50% | -42.20% | -48.08% |
| Normalized Diluted EPS | 22.85% | 2.53% | -17.76% | -42.44% | -48.14% |
| Average Basic Shares Outstanding | 90.68% | 61.17% | 36.87% | 12.82% | 12.34% |
| Average Diluted Shares Outstanding | 90.68% | 61.17% | 36.87% | 12.82% | 12.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |